SPX3,647.29-7.75 -0.21%
DIA291.30-1.42 -0.49%
IXIC10,829.50+26.58 0.25%

BRIEF-Lantern Pharma To Present Positive Preclinical Data On The Efficacy Of LP-184

BRIEF-Lantern Pharma To Present Positive Preclinical Data On The Efficacy Of LP-184

Reuters · 09/14/2022 08:51
BRIEF-Lantern Pharma To Present Positive Preclinical Data On The Efficacy Of LP-184

- Lantern Pharma Inc. LTRN.O:

  • LANTERN PHARMA TO PRESENT POSITIVE PRECLINICAL DATA ON THE EFFICACY OF LP-184 FOR PANCREATIC CANCER AT THE AACR SPECIAL CONFERENCE FOR PANCREATIC CANCER

Source text for Eikon: ID:

Further company coverage: LTRN.O


((Reuters.Briefs@thomsonreuters.com;))